Fortuna CG - Search Results

1

Exposition and reactivity optimization to predict sites of metabolism in chemicals.

Cruciani G, Baroni M, Benedetti P, Goracci L, Fortuna CG. Cruciani G, et al. Among authors: fortuna cg. Drug Discov Today Technol. 2013 Spring;10(1):e155-65. doi: 10.1016/j.ddtec.2012.11.001. Drug Discov Today Technol. 2013. PMID: 24050245

2

Structure-based rationalization of antitumor drugs mechanism of action by a MIF approach.

Cruciani G, Benedetti P, Caltabiano G, Condorelli DF, Fortuna CG, Musumarra G. Cruciani G, et al. Among authors: fortuna cg. Eur J Med Chem. 2004 Mar;39(3):281-9. doi: 10.1016/j.ejmech.2003.11.013. Eur J Med Chem. 2004. PMID: 15051177

3

Cyto- and enzyme toxicities of ionic liquids modelled on the basis of VolSurf+ descriptors and their principal properties.

Paternò A, Bocci G, Cruciani G, Fortuna CG, Goracci L, Sciré S, Musumarra G. Paternò A, et al. Among authors: fortuna cg. SAR QSAR Environ Res. 2016 Mar;27(3):221-244. doi: 10.1080/1062936X.2016.1156571. SAR QSAR Environ Res. 2016. PMID: 30950653

4

Modeling, design and synthesis of new heteroaryl ethylenes active against the MCF-7 breast cancer cell-line.

Barresi V, Bonaccorso C, Consiglio G, Goracci L, Musso N, Musumarra G, Satriano C, Fortuna CG. Barresi V, et al. Among authors: fortuna cg. Mol Biosyst. 2013 Oct;9(10):2426-9. doi: 10.1039/c3mb70151d. Mol Biosyst. 2013. PMID: 23900493

5

New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens.

Fortuna CG, Bonaccorso C, Bulbarelli A, Caltabiano G, Rizzi L, Goracci L, Musumarra G, Pace A, Palumbo Piccionello A, Guarcello A, Pierro P, Cocuzza CE, Musumeci R. Fortuna CG, et al. Eur J Med Chem. 2013 Jul;65:533-45. doi: 10.1016/j.ejmech.2013.03.069. Epub 2013 May 14. Eur J Med Chem. 2013. PMID: 23811204

6

Design, synthesis and in vitro antitumor activity of new trans 2-[2-(heteroaryl)vinyl]-1,3-dimethylimidazolium iodides.

Ballistreri FP, Barresi V, Benedetti P, Caltabiano G, Fortuna CG, Longo ML, Musumarra G. Ballistreri FP, et al. Among authors: fortuna cg. Bioorg Med Chem. 2004 Apr 1;12(7):1689-95. doi: 10.1016/j.bmc.2004.01.018. Bioorg Med Chem. 2004. PMID: 15028261

7

New potent antibacterials against Gram-positive multiresistant pathogens: effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazoles.

Fortuna CG, Berardozzi R, Bonaccorso C, Caltabiano G, Di Bari L, Goracci L, Guarcello A, Pace A, Palumbo Piccionello A, Pescitelli G, Pierro P, Lonati E, Bulbarelli A, Cocuzza CE, Musumarra G, Musumeci R. Fortuna CG, et al. Bioorg Med Chem. 2014 Dec 15;22(24):6814-25. doi: 10.1016/j.bmc.2014.10.037. Epub 2014 Nov 1. Bioorg Med Chem. 2014. PMID: 25464880

8

Design, synthesis and biological evaluation of trans 2-(thiophen-2-yl)vinyl heteroaromatic iodides.

Fortuna CG, Barresi V, Musumarra G. Fortuna CG, et al. Bioorg Med Chem. 2010 Jun 15;18(12):4516-23. doi: 10.1016/j.bmc.2010.04.060. Epub 2010 May 18. Bioorg Med Chem. 2010. PMID: 20488719

9

Design and synthesis of trans 2-(furan-2-yl)vinyl heteroaromatic iodides with antitumour activity.

Fortuna CG, Barresi V, Berellini G, Musumarra G. Fortuna CG, et al. Bioorg Med Chem. 2008 Apr 1;16(7):4150-9. doi: 10.1016/j.bmc.2007.12.042. Epub 2007 Dec 25. Bioorg Med Chem. 2008. PMID: 18248996

10

Genome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DA.

Musumarra G, Barresi V, Condorelli DF, Fortuna CG, Scirè S. Musumarra G, et al. Among authors: fortuna cg. Comput Biol Chem. 2005 Jun;29(3):183-95. doi: 10.1016/j.compbiolchem.2005.04.005. Comput Biol Chem. 2005. PMID: 15979038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters